Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Spectral Medical Inc
T.EDT
Alternate Symbol(s):
EDTXF
Healthcare
Biotechnology
Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis...
enabler. These devices have large commercial potential
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:EDT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(137)
•••
Spamme54321
X
View Profile
View Bullboard History
Comment by
Spamme54321
on Feb 22, 2024 2:20pm
RE:Today's Call
You got the major points. Some additional color. - They must read this message board because they addressed Kellum not being quoted on the recent news releases. Basiclly he is busy working on the
...more
(275)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Feb 22, 2024 2:14pm
RE:Today's Call
They said they were pleased with the results so far (or something like that) and they will no longer make comments such as @exceeding expectations!! Which also means I think that they will not
...more
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2%
posted May 28, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur's first international distribution agreement is over a three-year term with a company specializing in the sale of radiology products in Latin America. This initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal Computed Tomography (CT) diagnostic examinations. ...read more
(81)
•••
TechOne
X
View Profile
View Bullboard History
Post by
TechOne
on Feb 22, 2024 1:43pm
Today's Call
I did not listen to it so what I have summarized from posts here so please tell me know I got it.. Or not.. 1. Baxter made the extension deal and paid the 2nd milestone, CAD $ 2M without
...more
(206)
•••
ChesterLives
X
View Profile
View Bullboard History
Post by
ChesterLives
on Feb 22, 2024 1:28pm
Miniscule Volume
A poor presentation no doubt, but no one on consequence is selling here.
(804)
•••
mercedesman
X
View Profile
View Bullboard History
Comment by
mercedesman
on Feb 22, 2024 1:24pm
RE:RE:On balance …
Disagree totally that we'll see .30 again. If we do it'll be good for me. Although I like your ST Market Cap projection ( ST = less than one year) " I can see this
...more
(437)
•••
gebremeskel
X
View Profile
View Bullboard History
Comment by
gebremeskel
on Feb 22, 2024 1:01pm
RE:RE:RE:Data
On the call they talked about Baxter not wanting to take the "risk" of looking at data and the danger of released data being construed as an "interim analysis" that might
...more
(53)
•••
daviking
X
View Profile
View Bullboard History
Post by
daviking
on Feb 22, 2024 12:47pm
And here we go again!
Kicked down the road for another 6-12 months. Lots of ifs still in the cards. Stock price will take a hit, as usual. The company sure needs to get their PR calls done in a better fashion. How many
...more
(339)
•••
hmmmmmmmm
X
View Profile
View Bullboard History
Comment by
hmmmmmmmm
on Feb 22, 2024 12:47pm
RE:RE:Data
As per pg 14 and 18 of the Anual Meeting Presentation: "At 90 patients Baxter will have access to raw data (no statistical analysis)… potential opportunity to release crude data to broader
...more
(437)
•••
gebremeskel
X
View Profile
View Bullboard History
Comment by
gebremeskel
on Feb 22, 2024 12:20pm
RE:Milestone payment
Yes. They said on the call that the next payment would be at FDA approval.
(275)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Feb 22, 2024 12:16pm
RE:Data
Baxter did not exercise its right to access thr data,,,,,,weird!!
(275)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Feb 22, 2024 12:13pm
RE:2 milllions for 10 years exclusivity
The milestone payment was used as a carrot ahead of the 90 patient milestone and was not even mentioned in the PR....So Baxter will keep the exclusive right to distribute into a MULTI
...more
(437)
•••
gebremeskel
X
View Profile
View Bullboard History
Comment by
gebremeskel
on Feb 22, 2024 12:11pm
RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Spectral Medical Provides January Tigris Trial Update
As it turns out it was not an oversight. But it was not an occasion for hand-wringing either. They were just being more careful, which is all to the good. The poster with insight was Geery, who
...more
(192)
•••
BayStreetWild
X
View Profile
View Bullboard History
Comment by
BayStreetWild
on Feb 22, 2024 12:11pm
RE:On balance …
No, you can expect a financing and the price to go back to it's resting state in the 30s again.
(115)
•••
oilandgasman
X
View Profile
View Bullboard History
Post by
oilandgasman
on Feb 22, 2024 11:59am
Data
My phone when in and out a few times during the call, did Baxter even look at the Spectral data? Or was Baxter seeing the data another potental red flag from the FDA post 150? over all a very weird
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year